Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

ATC code L02

From Wikipedia, the free encyclopedia
Pharmaceutical drug classification
ATC code L: Antineoplastic and immunomodulating agents
Other ATC codes

ATC code L02Endocrine therapy is a therapeutic subgroup of theAnatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by theWorld Health Organization (WHO) for the classification ofdrugs and other medical products.[1][2][3] Subgroup L02 is part of the anatomical groupLAntineoplastic and immunomodulating agents.[4]

Codes forveterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example,QL02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L02A Hormones and related agents

[edit]

L02AA Estrogens

[edit]
L02AA01Diethylstilbestrol
L02AA02Polyestradiol phosphate
L02AA03Ethinylestradiol
L02AA04Fosfestrol

L02AB Progestogens

[edit]
L02AB01Megestrol
L02AB02Medroxyprogesterone
L02AB03Gestonorone

L02AE Gonadotropin-releasing hormone analogues

[edit]
L02AE01Buserelin
L02AE02Leuprorelin
L02AE03Goserelin
L02AE04Triptorelin
L02AE05Histrelin
L02AE51 Leuprorelin andbicalutamide

L02AX Other hormones

[edit]

L02B Hormone antagonists and related agents

[edit]

L02BA Anti-estrogens

[edit]
L02BA01Tamoxifen
L02BA02Toremifene
L02BA03Fulvestrant
L02BA04Elacestrant

L02BB Anti-androgens

[edit]
L02BB01Flutamide
L02BB02Nilutamide
L02BB03Bicalutamide
L02BB04Enzalutamide
L02BB05Apalutamide
L02BB06Darolutamide

L02BG Aromatase inhibitors

[edit]
L02BG01Aminogluthetimide
L02BG02Formestane
L02BG03Anastrozole
L02BG04Letrozole
L02BG05Vorozole
L02BG06Exemestane

L02BX Other hormone antagonists and related agents

[edit]
L02BX01Abarelix
L02BX02Degarelix
L02BX03Abiraterone
L02BX04Relugolix
L02BX53 Abiraterone andcorticosteroids

References

[edit]
  1. ^"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis".National Institutes of Health. Retrieved1 February 2020.
  2. ^"Anatomical Therapeutic Chemical (ATC) Classification".World Health Organization. Retrieved3 January 2022.
  3. ^"Structure and principles".WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved3 January 2022.
  4. ^"ATC/DDD Index 2022: code L02".WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^"ATCvet Index 2022: code QL02".WHO Collaborating Centre for Drug Statistics Methodology.
Androgens
(incl.AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptoragonists
Progonadotropins
Antiandrogens
ARTooltip Androgen receptorantagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
Progestogens
(andprogestins)
PRTooltip Progesterone receptoragonists
Antiprogestogens
SPRMsTooltip Selective progesterone receptor modulators
PRTooltip Progesterone receptorantagonists
GnRHTooltip Gonadotropin-releasing hormone andgonadotropins
GnRH modulators
(incl.analogues)
Agonists
Antagonists
Gonadotropins
Preparations
Others
(indirect)
Progonadotropins
Antigonadotropins
Retrieved from "https://en.wikipedia.org/w/index.php?title=ATC_code_L02&oldid=1264714796"
Category:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp